ADH1B and CDH1 polymorphisms predict prognosis in male patients with non-metastatic laryngeal cancer

4Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.

Abstract

In this study, we assessed the association between single nucleotide polymorphisms (SNPs) in candidate genes and the prognosis of laryngeal cancer (LC) patients. Thirty-seven SNPs in 26 genes were genotyped in 170 male Han Chinese patients with LC. The effects of the candidate genes on the prognosis of LC patients were evaluated using Kaplan-Meier curves and Cox proportional hazards regression models. The GA genotype of rs1229984 (hazard ratio [HR], 0.537; 95% confidence interval [CI], 0.340-0.848; p = 0.008) in alcohol dehydrogenase 1B (ADH1B), and the AA genotype of rs9929218 (HR, 6.074; 95% CI, 1.426-25.870; p = 0.015) in CDH1 were associated with overall survival. Our data suggest that polymorphisms in ADH1B and CDH1 may be prognostic indicators in LC.

Cite

CITATION STYLE

APA

Li, D., Zhang, R., Jin, T., He, N., Ren, L., Zhang, Z., … Gao, J. (2016). ADH1B and CDH1 polymorphisms predict prognosis in male patients with non-metastatic laryngeal cancer. Oncotarget, 7(45), 73216–73228. https://doi.org/10.18632/oncotarget.12301

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free